Fig. 1
Pyridoxamine (PM) scavenges neurotoxic dopamine quinone (DAQ) by forming the PL–DA adduct, and inhibits DA-induced oligomerization of α-synuclein (α-Syn).
Fig. 1 | Scientific Reports
Pyridoxamine (PM) scavenges neurotoxic dopamine quinone (DAQ) by forming the PL–DA adduct, and inhibits DA-induced oligomerization of α-synuclein (α-Syn).
